Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 6, 2007, Pages 772-778

  Li, Xue Song ^a   Li, Wei Qing ^a   Wang, Wen Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic trioxide; Drug therapy; Magnetic nanoparticles; Osteosarcoma

Indexed keywords

ARSENIC TRIOXIDE; CISPLATIN; NANOPARTICLE; POLYLACTIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; ELECTRON MICROSCOPY; ENCAPSULATION; HUMAN; HUMAN CELL; MAGNETIC FIELD; MAGNETOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BIOLOGICAL AVAILABILITY; CISPLATIN; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HUMANS; KIDNEY; LACTIC ACID; MAGNETICS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OSTEOSARCOMA; OXIDES; PARTICLE SIZE; POLYMERS; RABBITS; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 37549053612     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.352     Document Type: Article

References (13)

1. Liu Q, Hilsenbeck S, Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood 2003 May 15;101:4078.
2. Xiao T, Li KH, Fang JZ. [Experimental study on the apoptotic effect of arsenic trioxide on human osteosarcoma MG-63 cells]. Hunan Yi Ke Da Xue Xue Bao 2002;27:111.
3. Akao Y, Nakagawa Y, Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase-3 in vitro. FEBS Lett 1999;455(1-2):59.
4. Berry CC, Rudershausen S, Teller J, et al. The influence of elastin-coated 520- and 20-nm-diameter nanoparticles on human fibroblasts in vitro. IEEE Trans Nanobiosci 2002;1:105.
5. Chiang CL, Sung CS, Wu TF, et al. Application of superparamagnetic nanoparticles in purification of plasmid DNA from bacterial cells. J Chromatogr B Anal Technol Biomed Life Sci 2005;822(1-2):54.
6. Seyler I, Appel M, Devissaguet JP, et al. Relationship between NO-synthase activity and TNF-alpha secretion in mouse macrophage lines stimulated by a muramyl peptide entrapped in nanocapsules. Int J Immunopharmacol 1996;18(6-7):385.
7. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR Am J Roentgenol 1989;152(1):167.
8. Li YP, Zhou ZH, Pei YY, et al. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: Synthesis, preparation, and in vitro characterization. Acta Pharmacol Sin 2001;22(7):645.
9. Jie P, Venkatraman SS, Min F, et al. Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier. J Contr Rel 2005;110:20.
10. Bramwell VH. Osteosarcomas and other cancers of bone. Curr Opin Oncol 2000;12:330.
11. Cai X, Shen YL, Zhu Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000;14:262.
12. Jiang XH, Wong BC, Yuen ST, et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through upregulation of p53 and activation of caspase-3. Int J Cancer 2001;91:173.
13. Park WH, Seol JG, Kim ES, et al. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell-cycle arrest in association with induction of cyclindependent kinase inhibitor, p21, and apoptosis. Cancer Res 2000;60:3065.